137 related articles for article (PubMed ID: 38063920)
1. Knockdown of ADAMDEC1 ameliorates ox-LDL-induced endothelial cell injury and atherosclerosis progression.
Wang X; Gao F; Cheng C; Zhang Y
Funct Integr Genomics; 2023 Dec; 24(1):1. PubMed ID: 38063920
[TBL] [Abstract][Full Text] [Related]
2. Salvianolic acid B inhibits atherosclerosis and TNF-α-induced inflammation by regulating NF-κB/NLRP3 signaling pathway.
Zhao Y; Shao C; Zhou H; Yu L; Bao Y; Mao Q; Yang J; Wan H
Phytomedicine; 2023 Oct; 119():155002. PubMed ID: 37572566
[TBL] [Abstract][Full Text] [Related]
3. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
4. MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis.
Yang L; Gao C
Yonsei Med J; 2019 Mar; 60(3):298-307. PubMed ID: 30799593
[TBL] [Abstract][Full Text] [Related]
5. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
Guo X; Liu Y; Zheng X; Han Y; Cheng J
Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of Buyang Huanwu Decoction glycosides against atherosclerotic inflammation through NF-κB signaling pathway].
Fu XY; Sun ZJ; Long QY; Tan W; Li YJ; Wu L; He QH; Zhang W
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):202-210. PubMed ID: 36725272
[TBL] [Abstract][Full Text] [Related]
7. Circ_UBR4 Knockdown Alleviates Oxidized Low-Density Lipoprotein-Provoked Growth and Migration of Human Vascular Smooth Muscle Cells by Acting on the miR-637/FOXO4 Pathway.
Ding Y; Tang T; Lu J; Wang J
J Cardiovasc Pharmacol; 2021 Oct; 78(4):534-543. PubMed ID: 34225339
[TBL] [Abstract][Full Text] [Related]
8. HOTAIR alleviates ox-LDL-induced inflammatory response in Raw264.7 cells via inhibiting NF-κB pathway.
Pang JL; Wang JW; Hu PY; Jiang JS; Yu C
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6991-6998. PubMed ID: 30402866
[TBL] [Abstract][Full Text] [Related]
9. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
10. Circ_0003575 knockdown alleviates ox-LDL-induced human aortic endothelial cell dysfunction in atherosclerosis by miR-637/TRAF6 axis.
Zhang Z; Qin S; Wang R; Fang Z; Wang Y; Li F
Clin Hemorheol Microcirc; 2023; 85(2):173-187. PubMed ID: 37599528
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
[TBL] [Abstract][Full Text] [Related]
12. Hexarelin attenuates atherosclerosis via inhibiting LOX-1-NF-κB signaling pathway-mediated macrophage ox-LDL uptake in ApoE
Cheng XL; Ding F; Wang DP; Zhou L; Cao JM
Peptides; 2019 Nov; 121():170122. PubMed ID: 31386895
[TBL] [Abstract][Full Text] [Related]
13. miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3/PIK3R1/Akt pathway and induces endothelial cell injury and lipid accumulation.
Li H; Song D; Liu Q; Li L; Sun X; Guo J; Li D; Li P
Mol Med; 2022 Sep; 28(1):120. PubMed ID: 36180828
[TBL] [Abstract][Full Text] [Related]
14. The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation.
Wang Z; Chen J; Zeng Z; Zhang Q; Du G; Guo X; Wei Y
Mol Med; 2022 Mar; 28(1):26. PubMed ID: 35236285
[TBL] [Abstract][Full Text] [Related]
15. LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis.
Zheng Z; Zhang G; Liang X; Li T
Mol Cell Biochem; 2021 Jan; 476(1):443-455. PubMed ID: 32990894
[TBL] [Abstract][Full Text] [Related]
16. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.
Liu Z; Han Y; Li L; Lu H; Meng G; Li X; Shirhan M; Peh MT; Xie L; Zhou S; Wang X; Chen Q; Dai W; Tan CH; Pan S; Moore PK; Ji Y
Br J Pharmacol; 2013 Aug; 169(8):1795-809. PubMed ID: 23713790
[TBL] [Abstract][Full Text] [Related]
17. Role of Ox-LDL/LOX-1/NF-κB signaling pathway in regulation of atherosclerotic plaque growth by testosterone in male rabbits.
Li S; Guo Y; Zhu P; Yang T
Vascul Pharmacol; 2013; 59(5-6):131-7. PubMed ID: 23022624
[TBL] [Abstract][Full Text] [Related]
18. CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation.
Chang TT; Yang HY; Chen C; Chen JW
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911750
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- mice.
Zhuang J; Peng W; Li H; Lu Y; Wang K; Fan F; Li S; Xu Y
PLoS One; 2013; 8(12):e82509. PubMed ID: 24349299
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of liquiritin on coronary heart disease through regulating the proliferation of human vascular smooth muscle cells via upregulation of sirtuin1.
Yuan L; Wang D; Wu C
Bioengineered; 2022 Feb; 13(2):2840-2850. PubMed ID: 35038972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
